Recent trends in epidemiology of dyslipidemias in India: Key takeaways Medha Baranwal27 Feb 2024 7:17 PM ISTIndia: A recent study published in the Indian Heart Journal has shed light on the trends in the epidemiology of dyslipidemias in India.Dyslipidemia is...
Extended use of inclisiran safe and efficacious among refractory dyslipidemia in patients with increased CV risk Dr Riya Dave29 Dec 2023 8:45 PM ISTA recent study sheds light on the safety profile of inclisiran, an innovative agent designed to reduce low-density lipoprotein cholesterol (LDL-C)....
Study finds no Direct Association Between Cholesterol Intake and Chronic Kidney Disease Risk Dr Riya Dave21 Dec 2023 11:15 AM ISTA recent investigation exploring the link between cholesterol intake and the risk of chronic kidney disease (CKD) has yielded intriguing insights,...
Vitamin D supplementation beneficial in managing dyslipidemia Aditi15 Nov 2023 2:00 AM ISTVitamin D supplementation benefits lipid profile and is beneficial as a dietary intervention for managing dyslipidemia, says Nima Radkhah and...
Longer the duration of HRT in women greater the risk of nonarteritic anterior ischemic optic neuropathy Niveditha Subramani7 Aug 2023 8:00 PM ISTNon-arteritic anterior ischemic optic neuropathy (NAION) is a condition caused due to impaired circulation of blood to the front of the optic nerve....
Obicetrapib addition to statins and ezetimibe safe and effective for LDL-C reduction and ASCVD prevention Medha Baranwal16 Jun 2023 11:15 AM ISTUSA: Obicetrapib could be used safely in high-intensity statin and ezetimibe in patients with elevated LDL-C (low-density lipoprotein-cholesterol),...
Combo of obicetrapib plus ezetimibe effective adjunct therapy for dyslipidemia patients Dr. Kamal Kant Kohli7 Jun 2023 11:15 AM ISTUSA: A recent study has highlighted the potential of obicetrapib plus ezetimibe as an effective adjunct to high-intensity statin therapy for patients...
Significant serum cystatin C and lipoprotein abnormalities found in type 2 diabetes patients with nephropathy: Study Medha Baranwal3 May 2023 9:45 AM ISTEthiopia: A recent study published in Frontiers in Endocrinology has revealed a significant serum cystatin C and lipoprotein in type 2 diabetes...
Astaxanthin lowers cholesterol and CVD risk in people with prediabetes and dyslipidemia Medha Baranwal6 April 2023 11:30 AM ISTUSA: A recent study published in Diabetes, Obesity and Metabolism has shown that astaxanthin, a natural antioxidant is a safe over-the-counter (OTC)...
LAI issues expert consensus statement on management of diabetic dyslipidemia in Indians Medha Baranwal24 March 2023 8:00 PM ISTRajasthan: An article published in the Journal of Clinical Lipidology reports an expert consensus statement from the Lipid Association of India...
Primordial dyslipidemia prevention in childhood critical for reducing atherosclerosis development Medha Baranwal24 March 2023 10:45 AM ISTFinland: A recent study published in the Journal of the American Heart Association has suggested that treating or preventing dyslipidaemia in...
Cinnamon intake improves dyslipidaemia particularly in PCOS patients Dr. Nandita Mohan24 March 2023 9:00 AM ISTCinnamon is a polyphenol-rich spice that might be the oldest known spice in the world and in ancient Egypt, it was more valuable than gold. Cinnamon...
